Mechanism of action of cannabis
Pro Research Analysisby 
Searched over 200M research papers
Cannabinoids and the Endocannabinoid System: Mechanism of Action
Cannabis contains over 100 cannabinoids, with Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) being the most studied. These compounds primarily act through the endocannabinoid system, which includes cannabinoid receptors (CB1 and CB2), endogenous ligands, and enzymes for synthesis and degradation of these ligands 1234+2 MORE.
THC: CB1 and CB2 Receptor Activation
THC is the main psychoactive component of cannabis. It acts as a partial agonist at both CB1 and CB2 receptors, which are G protein-coupled receptors. CB1 receptors are highly expressed in the brain, especially in areas like the basal ganglia, cerebellum, and hippocampus, but are scarce in the brainstem regions that control breathing. CB2 receptors are mainly found in immune cells and peripheral tissues 1234+4 MORE. By binding to these receptors, THC modulates neurotransmitter release, leading to effects such as euphoria, relaxation, altered perception, and appetite stimulation. It is also used therapeutically for nausea, appetite loss, and chronic pain 1347+1 MORE.
CBD: Multiple Molecular Targets
CBD, unlike THC, does not produce intoxicating effects. Its mechanism is more complex and involves multiple molecular targets. CBD acts as a noncompetitive negative allosteric modulator of the CB1 receptor and as an inverse agonist at the CB2 receptor. It also inhibits the reuptake of the endocannabinoid anandamide, increases its levels, and interacts with other receptors such as 5-HT1A (serotonin) and vanilloid receptors (TRPV1) 1357+1 MORE. CBD’s broad action profile is thought to underlie its anxiolytic, antipsychotic, anti-inflammatory, and anticonvulsant effects. It is approved for use in certain treatment-resistant epilepsy syndromes 3510.
Polypharmacology and Additional Targets
Cannabis and its cannabinoids exhibit “promiscuous” pharmacology, meaning they interact with many molecular targets beyond the endocannabinoid system. CBD alone has been identified to affect at least 56 different molecular targets, including enzymes, ion channels, and other metabotropic receptors involved in neurological and inflammatory conditions 5710. This broad spectrum of action contributes to the wide range of therapeutic effects and potential side effects seen with cannabis-based products 3578.
Immune System and Inflammation
Cannabinoids, particularly through CB2 receptor activation, can modulate immune cell activity and inflammation. This has led to interest in their potential for treating autoimmune and inflammatory diseases, although more in vivo research is needed to fully understand these effects in humans 678.
Conclusion
The mechanism of action of cannabis is complex and involves the activation and modulation of the endocannabinoid system, primarily through CB1 and CB2 receptors. THC acts mainly as a partial agonist at these receptors, while CBD interacts with a wide array of molecular targets, including but not limited to cannabinoid receptors. This polypharmacological nature underlies the diverse therapeutic and psychoactive effects of cannabis and highlights the need for further research to fully understand its mechanisms and optimize its medical use 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic